Literature DB >> 3753454

Site-specific modification of albumin by free radicals. Reaction with copper(II) and ascorbate.

G Marx, M Chevion.   

Abstract

Exposure of albumin to Cu(II) (10-100 microM) and ascorbate (0.1-2 mM) results in extensive molecular modifications, indicated by decreased fluorescence and chain breaks. The rate of utilization of molecular oxygen and ascorbate as a function of Cu(II) concentration is non-linear at copper/albumin ratios of greater than 1. It appears that Cu(II) bound to the tightest albumin-binding site is less available to the ascorbate than the more loosely bound cation. SDS/polyacrylamide-gel electrophoresis reveals new protein bands corresponding to 50, 47, 22, 18 and 3 kDa. For such a cleavage pattern, relatively few (approximately 3) and rather specific chain breaks occurred. Repeated addition of portions of ascorbate to the albumin/Cu(II) mixture results in increased intensity of the new bands. The absence of Cu(II) or the presence of metal chelating agents is inhibitory. There was no evidence of intermolecular cross-linking or of the formation of insoluble, albumin-derived, material. A mechanism is proposed wherein the loosely bound Cu(II) participates in a Fenton-type reaction. This generates OH. radicals, which rapidly inter-react with the protein and modify it in a 'site-specific' manner.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753454      PMCID: PMC1146853          DOI: 10.1042/bj2360397

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  The amino acid sequence of peptide (1-24) of rat and human serum albumins.

Authors:  R A Bradshaw; T Peters
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

2.  Ternary coordination complex between human serum albumin, copper (II), and L-histidine.

Authors:  S J Lau; B Sarkar
Journal:  J Biol Chem       Date:  1971-10-10       Impact factor: 5.157

3.  Sites of binding of copper (II) ion by peptide (1-24) of bovine serum albumin.

Authors:  R A Bradshaw; W T Shearer; F R Gurd
Journal:  J Biol Chem       Date:  1968-07-25       Impact factor: 5.157

4.  The binding of ascorbate to bovine serum albumin.

Authors:  B A Oelrichs; C C Kratzing; J D Kelly; D J Winzor
Journal:  Int J Vitam Nutr Res       Date:  1984       Impact factor: 1.784

5.  Fibrinogen coagulation without thrombin: reaction with vitamin C and copper(II).

Authors:  G Marx; M Chevion
Journal:  Thromb Res       Date:  1985-10-01       Impact factor: 3.944

6.  Reversible oxidant-induced increases in albumin transfer across cultured endothelium: alterations in cell shape and calcium homeostasis.

Authors:  D M Shasby; S E Lind; S S Shasby; J C Goldsmith; G W Hunninghake
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

7.  The role of ascorbic acid in senile cataract.

Authors:  K G Bensch; J E Fleming; W Lohmann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

8.  Oxygen effect in the radiolysis of proteins. Part 2. Bovine serum albumin.

Authors:  H Schuessler; K Schilling
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1984-03

9.  Oxidative modification of glutamine synthetase. II. Characterization of the ascorbate model system.

Authors:  R L Levine
Journal:  J Biol Chem       Date:  1983-10-10       Impact factor: 5.157

10.  Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals in the presence of copper salts: a physiologically significant reaction?

Authors:  D A Rowley; B Halliwell
Journal:  Arch Biochem Biophys       Date:  1983-08       Impact factor: 4.013

View more
  31 in total

1.  Biotherapeutic formulation factors affecting metal leachables from stainless steel studied by design of experiments.

Authors:  Shuxia Zhou; Brad Evans; Christian Schöneich; Satish K Singh
Journal:  AAPS PharmSciTech       Date:  2012-01-13       Impact factor: 3.246

2.  Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin.

Authors:  D Roy; J Quiles; D C Gaze; P Collinson; J C Kaski; G F Baxter
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

3.  Structural modifications of human beta 2 microglobulin treated with oxygen-derived radicals.

Authors:  C Capeillere-Blandin; T Delaveau; B Descamps-Latscha
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

4.  Effects of oxidative stress on some physiochemical properties of caeruloplasmin.

Authors:  P G Winyard; R C Hider; S Brailsford; A F Drake; J Lunec; D R Blake
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

5.  The pyridoindole antioxidant stobadine inhibited glycation-induced absorbance and fluorescence changes in albumin.

Authors:  M Stefek; I Drozdikova; K Vajdova
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

6.  Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulphates.

Authors:  Martin D Rees; Clare L Hawkins; Michael J Davies
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

7.  Estimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome.

Authors:  Prema Gurumurthy; Sai Krishna Borra; Rama Krishna Reddy Yeruva; Dolice Victor; Sai Babu; K M Cherian
Journal:  Indian J Clin Biochem       Date:  2013-08-10

8.  Effect of pH, phosphate and copper on the interaction of glucose with albumin.

Authors:  F Tessier; I Birlouez-Aragon
Journal:  Glycoconj J       Date:  1998-06       Impact factor: 2.916

9.  Oxygen radical induced fluorescence in proteins; identification of the fluorescent tryptophan metabolite, N-formyl kynurenine, as a biological index of radical damage.

Authors:  H R Griffiths; J Lunec; D R Blake
Journal:  Amino Acids       Date:  1992-06       Impact factor: 3.520

10.  Formation of peroxides in amino acids and proteins exposed to oxygen free radicals.

Authors:  S Gebicki; J M Gebicki
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.